Biochemical and genetic factors regulating dilantin metabolism in man.
D000636:Aminosalicylic Acids / Q000494:pharmacology; D000818:Animals; D001259:Ataxia / Q000139:chemically induced; D002415:Cats; D002706:Chlordan / Q000494:pharmacology; D003523:Cycloserine / Q000494:pharmacology; D003634:DDT / Q000494:pharmacology; D001728:Dicumarol / Q000494:pharmacology; D004221:Disulfiram / Q000494:pharmacology; D004790:Enzyme Induction; D005260:Female; D005826:Genetics, Medical; D006801:Humans; D007408:Intestinal Absorption; D007538:Isoniazid / Q000378:metabolism / Q000494:pharmacology; D007700:Kinetics; D008107:Liver Diseases / Q000378:metabolism; D008297:Male; D008660:Metabolism / Q000187:drug effects; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D009759:Nystagmus, Pathologic / Q000139:chemically induced; D010375:Pedigree; D010597:Pharmacogenetics; D010634:Phenobarbital / Q000494:pharmacology; D010672:Phenytoin / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000378:metabolism*; D051381:Rats; D013843:Thiazines / Q000494:pharmacology
D000636:Aminosalicylic Acids; D013843:Thiazines; D002706:Chlordan; D010672:Phenytoin; D001728:Dicumarol; D003523:Cycloserine; D003634:DDT; D004221:Disulfiram; D007538:Isoniazid; D010634:Phenobarbital